Watch Demo

Global Sexually Transmitted Disease (STD) Testing Market 2023-2027

Global Sexually Transmitted Disease (STD) Testing Market 2023-2027

  • Publish Date:November 2022

  • Number of Pages:120

  • Report ID:5800715

  • Format:PDF

  • Publisher:Infiniti Research Limited

$ 2500

Summary

Global Sexually Transmitted Disease (STD) Testing Market 2023-2027
The analyst has been monitoring the sexually transmitted disease (STD) testing market and it is poised to grow by $29988.27 mn during 2023-2027, accelerating at a CAGR of 5.46% during the forecast period. Our report on the sexually transmitted disease (STD) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of STDs, presence of favorable reimbursement policies, and increased initiatives by governments worldwide.

The sexually transmitted disease (STD) testing market is segmented as below:
By Disease Type
• Chlamydia
• Gonorrhea
• Syphilis
• Trichomoniasis
• Others

By Product
• Laboratory testing device
• POC testing device

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advances in rapid diagnosis of STDs as one of the prime reasons driving the sexually transmitted disease (STD) testing market growth during the next few years. Also, increasing involvement of various organizations to create awareness about STDs and expedited partner therapy (EPT) will lead to sizable demand in the market.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the sexually transmitted disease (STD) testing market covers the following areas:
• Sexually transmitted disease (STD) testing market sizing
• Sexually transmitted disease (STD) testing market forecast
• Sexually transmitted disease (STD) testing market industry analysis

This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading sexually transmitted disease (STD) testing market vendors that include AbbVie Inc., AccuBioTech Co. Ltd., AdvaCare Pharma, BIOGENIX Inc. Pvt. Ltd., CTK Biotech Inc., Everlywell Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Goffin Molecular Technologies, Hangzhou Biotest Biotech Co. Ltd., Hologic Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, LT Labs, Merck and Co. Inc., OK Biotech Co. Ltd., Priority STD Testing, QIAGEN NV, and RayBiotech Life Inc. Also, the sexually transmitted disease (STD) testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of contents

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global sexually transmitted disease (STD) testing market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global sexually transmitted disease (STD) testing market 2017 - 2021 ($ million)

4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)

4.3 Disease type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)

4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)

4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027

5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Disease Type

6.1 Market segments
Exhibit 30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Disease Type - Market share 2022-2027 (%)

6.2 Comparison by Disease Type
Exhibit 32: Chart on Comparison by Disease Type
Exhibit 33: Data Table on Comparison by Disease Type

6.3 Chlamydia - Market size and forecast 2022-2027
Exhibit 34: Chart on Chlamydia - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Chlamydia - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Chlamydia - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Chlamydia - Year-over-year growth 2022-2027 (%)

6.4 Gonorrhea - Market size and forecast 2022-2027
Exhibit 38: Chart on Gonorrhea - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Gonorrhea - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Gonorrhea - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Gonorrhea - Year-over-year growth 2022-2027 (%)

6.5 Syphilis - Market size and forecast 2022-2027
Exhibit 42: Chart on Syphilis - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Syphilis - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Syphilis - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Syphilis - Year-over-year growth 2022-2027 (%)

6.6 Trichomoniasis - Market size and forecast 2022-2027
Exhibit 46: Chart on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Trichomoniasis - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Trichomoniasis - Year-over-year growth 2022-2027 (%)

6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)

6.8 Market opportunity by Disease Type
Exhibit 54: Market opportunity by Disease Type ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 55: Chart on Product - Market share 2022-2027 (%)
Exhibit 56: Data Table on Product - Market share 2022-2027 (%)

7.2 Comparison by Product
Exhibit 57: Chart on Comparison by Product
Exhibit 58: Data Table on Comparison by Product

7.3 Laboratory testing device - Market size and forecast 2022-2027
Exhibit 59: Chart on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Laboratory testing device - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Laboratory testing device - Year-over-year growth 2022-2027 (%)

7.4 POC testing device - Market size and forecast 2022-2027
Exhibit 63: Chart on POC testing device - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on POC testing device - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on POC testing device - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on POC testing device - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by Product
Exhibit 67: Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)

9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.9 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.10 Canada - Market size and forecast 2022-2027
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)

9.11 China - Market size and forecast 2022-2027
Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption

11.4 Industry risks
Exhibit 113: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 114: Vendors covered

12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification

12.3 AbbVie Inc.
Exhibit 116: AbbVie Inc. - Overview
Exhibit 117: AbbVie Inc. - Product / Service
Exhibit 118: AbbVie Inc. - Key offerings

12.4 AccuBioTech Co. Ltd.
Exhibit 119: AccuBioTech Co. Ltd. - Overview
Exhibit 120: AccuBioTech Co. Ltd. - Product / Service
Exhibit 121: AccuBioTech Co. Ltd. - Key offerings

12.5 AdvaCare Pharma
Exhibit 122: AdvaCare Pharma - Overview
Exhibit 123: AdvaCare Pharma - Product / Service
Exhibit 124: AdvaCare Pharma - Key offerings

12.6 BIOGENIX Inc. Pvt. Ltd.
Exhibit 125: BIOGENIX Inc. Pvt. Ltd. - Overview
Exhibit 126: BIOGENIX Inc. Pvt. Ltd. - Product / Service
Exhibit 127: BIOGENIX Inc. Pvt. Ltd. - Key offerings

12.7 F. Hoffmann La Roche Ltd.
Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus

12.8 Gilead Sciences Inc.
Exhibit 133: Gilead Sciences Inc. - Overview
Exhibit 134: Gilead Sciences Inc. - Product / Service
Exhibit 135: Gilead Sciences Inc. - Key news
Exhibit 136: Gilead Sciences Inc. - Key offerings

12.9 GlaxoSmithKline Plc
Exhibit 137: GlaxoSmithKline Plc - Overview
Exhibit 138: GlaxoSmithKline Plc - Business segments
Exhibit 139: GlaxoSmithKline Plc - Key offerings
Exhibit 140: GlaxoSmithKline Plc - Segment focus

12.10 Hologic Inc.
Exhibit 141: Hologic Inc. - Overview
Exhibit 142: Hologic Inc. - Business segments
Exhibit 143: Hologic Inc. - Key news
Exhibit 144: Hologic Inc. - Key offerings
Exhibit 145: Hologic Inc. - Segment focus

12.11 Inovio Pharmaceuticals Inc.
Exhibit 146: Inovio Pharmaceuticals Inc. - Overview
Exhibit 147: Inovio Pharmaceuticals Inc. - Product / Service
Exhibit 148: Inovio Pharmaceuticals Inc. - Key news
Exhibit 149: Inovio Pharmaceuticals Inc. - Key offerings

12.12 Johnson and Johnson
Exhibit 150: Johnson and Johnson - Overview
Exhibit 151: Johnson and Johnson - Business segments
Exhibit 152: Johnson and Johnson - Key news
Exhibit 153: Johnson and Johnson - Key offerings
Exhibit 154: Johnson and Johnson - Segment focus

12.13 Merck and Co. Inc.
Exhibit 155: Merck and Co. Inc. - Overview
Exhibit 156: Merck and Co. Inc. - Business segments
Exhibit 157: Merck and Co. Inc. - Key news
Exhibit 158: Merck and Co. Inc. - Key offerings
Exhibit 159: Merck and Co. Inc. - Segment focus

12.14 OK Biotech Co. Ltd.
Exhibit 160: OK Biotech Co. Ltd. - Overview
Exhibit 161: OK Biotech Co. Ltd. - Product / Service
Exhibit 162: OK Biotech Co. Ltd. - Key offerings

12.15 Priority STD Testing
Exhibit 163: Priority STD Testing - Overview
Exhibit 164: Priority STD Testing - Product / Service
Exhibit 165: Priority STD Testing - Key offerings

12.16 QIAGEN NV
Exhibit 166: QIAGEN NV - Overview
Exhibit 167: QIAGEN NV - Product / Service
Exhibit 168: QIAGEN NV - Key news
Exhibit 169: QIAGEN NV - Key offerings

12.17 RayBiotech Life Inc.
Exhibit 170: RayBiotech Life Inc. - Overview
Exhibit 171: RayBiotech Life Inc. - Product / Service
Exhibit 172: RayBiotech Life Inc. - Key offerings

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
Exhibit 173: Inclusions checklist
Exhibit 174: Exclusions checklist

13.3 Currency conversion rates for US$
Exhibit 175: Currency conversion rates for US$

13.4 Research methodology
Exhibit 176: Research methodology
Exhibit 177: Validation techniques employed for market sizing
Exhibit 178: Information sources

13.5 List of abbreviations
Exhibit 179: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global sexually transmitted disease (STD) testing market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Disease type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Disease Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Disease Type
Exhibits33: Data Table on Comparison by Disease Type
Exhibits34: Chart on Chlamydia - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Chlamydia - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Chlamydia - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Chlamydia - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Gonorrhea - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Gonorrhea - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Gonorrhea - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Gonorrhea - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Syphilis - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Syphilis - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Syphilis - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Syphilis - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Trichomoniasis - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Trichomoniasis - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Trichomoniasis - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Disease Type ($ million)
Exhibits55: Chart on Product - Market share 2022-2027 (%)
Exhibits56: Data Table on Product - Market share 2022-2027 (%)
Exhibits57: Chart on Comparison by Product
Exhibits58: Data Table on Comparison by Product
Exhibits59: Chart on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Laboratory testing device - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Laboratory testing device - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Laboratory testing device - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on POC testing device - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on POC testing device - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on POC testing device - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on POC testing device - Year-over-year growth 2022-2027 (%)
Exhibits67: Market opportunity by Product ($ million)
Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits71: Chart on Geographic comparison
Exhibits72: Data Table on Geographic comparison
Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits109: Market opportunity By Geographical Landscape ($ million)
Exhibits110: Impact of drivers and challenges in 2022 and 2027
Exhibits111: Overview on Criticality of inputs and Factors of differentiation
Exhibits112: Overview on factors of disruption
Exhibits113: Impact of key risks on business
Exhibits114: Vendors covered
Exhibits115: Matrix on vendor position and classification
Exhibits116: AbbVie Inc. - Overview
Exhibits117: AbbVie Inc. - Product / Service
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: AccuBioTech Co. Ltd. - Overview
Exhibits120: AccuBioTech Co. Ltd. - Product / Service
Exhibits121: AccuBioTech Co. Ltd. - Key offerings
Exhibits122: AdvaCare Pharma - Overview
Exhibits123: AdvaCare Pharma - Product / Service
Exhibits124: AdvaCare Pharma - Key offerings
Exhibits125: BIOGENIX Inc. Pvt. Ltd. - Overview
Exhibits126: BIOGENIX Inc. Pvt. Ltd. - Product / Service
Exhibits127: BIOGENIX Inc. Pvt. Ltd. - Key offerings
Exhibits128: F. Hoffmann La Roche Ltd. - Overview
Exhibits129: F. Hoffmann La Roche Ltd. - Business segments
Exhibits130: F. Hoffmann La Roche Ltd. - Key news
Exhibits131: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits133: Gilead Sciences Inc. - Overview
Exhibits134: Gilead Sciences Inc. - Product / Service
Exhibits135: Gilead Sciences Inc. - Key news
Exhibits136: Gilead Sciences Inc. - Key offerings
Exhibits137: GlaxoSmithKline Plc - Overview
Exhibits138: GlaxoSmithKline Plc - Business segments
Exhibits139: GlaxoSmithKline Plc - Key offerings
Exhibits140: GlaxoSmithKline Plc - Segment focus
Exhibits141: Hologic Inc. - Overview
Exhibits142: Hologic Inc. - Business segments
Exhibits143: Hologic Inc. - Key news
Exhibits144: Hologic Inc. - Key offerings
Exhibits145: Hologic Inc. - Segment focus
Exhibits146: Inovio Pharmaceuticals Inc. - Overview
Exhibits147: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits148: Inovio Pharmaceuticals Inc. - Key news
Exhibits149: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits150: Johnson and Johnson - Overview
Exhibits151: Johnson and Johnson - Business segments
Exhibits152: Johnson and Johnson - Key news
Exhibits153: Johnson and Johnson - Key offerings
Exhibits154: Johnson and Johnson - Segment focus
Exhibits155: Merck and Co. Inc. - Overview
Exhibits156: Merck and Co. Inc. - Business segments
Exhibits157: Merck and Co. Inc. - Key news
Exhibits158: Merck and Co. Inc. - Key offerings
Exhibits159: Merck and Co. Inc. - Segment focus
Exhibits160: OK Biotech Co. Ltd. - Overview
Exhibits161: OK Biotech Co. Ltd. - Product / Service
Exhibits162: OK Biotech Co. Ltd. - Key offerings
Exhibits163: Priority STD Testing - Overview
Exhibits164: Priority STD Testing - Product / Service
Exhibits165: Priority STD Testing - Key offerings
Exhibits166: QIAGEN NV - Overview
Exhibits167: QIAGEN NV - Product / Service
Exhibits168: QIAGEN NV - Key news
Exhibits169: QIAGEN NV - Key offerings
Exhibits170: RayBiotech Life Inc. - Overview
Exhibits171: RayBiotech Life Inc. - Product / Service
Exhibits172: RayBiotech Life Inc. - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Validation techniques employed for market sizing
Exhibits178: Information sources
Exhibits179: List of abbreviations

Companies Mentioned
AbbVie Inc.
AccuBioTech Co. Ltd.
AdvaCare Pharma
BIOGENIX Inc. Pvt. Ltd.
CTK Biotech Inc.
Everlywell Inc.
F. Hoffmann La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline Plc
Goffin Molecular Technologies
Hangzhou Biotest Biotech Co. Ltd.
Hologic Inc.
Inovio Pharmaceuticals Inc.
Johnson and Johnson
LT Labs
Merck and Co. Inc.
OK Biotech Co. Ltd.
Priority STD Testing
QIAGEN NV
RayBiotech Life Inc.

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.